Skip to content
← Full study record

NCT01208103 · MORE INFO

Limitations, agreements, and source contact

Bevacizumab, Capecitabine, and Oxaliplatin in Treating Advanced Small Intestinal or Ampulla of Vater Adenocarcinoma · Source last updated 2020-09-03

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement
pi Sponsor Employee
true
point Of Contact
email
MOverman@mdanderson.org
organization
UT MD Anderson Cancer Center
phone
713-745-4317
title
Dr. Michael Overman/Gastrointestinal Medical Oncology
Complete source fields
certain Agreement
pi Sponsor Employee
true
point Of Contact
email
MOverman@mdanderson.org
organization
UT MD Anderson Cancer Center
phone
713-745-4317
title
Dr. Michael Overman/Gastrointestinal Medical Oncology

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice